Development and validation of a nomogram to predict liver metastasis in patients with pancreatic ductal adenocarcinoma: a large cohort study

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Bockhorn M, Uzunoglu FG, Adham M, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2014;155(6):977–988. doi:10.1016/j.surg.2014.02.00124856119
   PubMed Web of Science ®Google Scholar
• Shi S, Yu XJ. Time to think: selecting patients who may benefit from synchronous resection of primary pancreatic cancer and liver metastases. World J Gastroenterol. 2018;24(33):3677–3680. doi:10.3748/wjg.v24.i33.367730197474
   PubMed Web of Science ®Google Scholar
• He C, Zhang Y, Cai Z, Lin X, Li S. Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: a competing risk nomogram analysis. J Cancer. 2018;9(17):3156–3167. doi:10.7150/jca.2549430210639
   PubMed Web of Science ®Google Scholar
• Spadi R, Brusa F, Ponzetti A, et al. Current therapeutic strategies for advanced pancreatic cancer: a review for clinicians. World J Clin Oncol. 2016;7(1):27–43. doi:10.5306/wjco.v7.i1.2726862489
   PubMedGoogle Scholar
• Oweira H, Petrausch U, Helbling D, et al. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: a Surveillance Epidemiology and End Results database analysis. World J Gastroenterol. 2017;23(10):1872–1880. doi:10.3748/wjg.v23.i10.187228348494
   PubMed Web of Science ®Google Scholar
• Schneitler S, Kropil P, Riemer J, et al. Metastasized pancreatic carcinoma with neoadjuvant FOLFIRINOX therapy and R0 resection. World J Gastroenterol. 2015;21(20):6384–6390. doi:10.3748/wjg.v21.i20.638426034375
   PubMed Web of Science ®Google Scholar
• Torphy RJ, Tignanelli CJ, Kamande JW, et al. Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma. PLoS One. 2014;9(2):e89474. doi:10.1371/journal.pone.008947424586805
   PubMed Web of Science ®Google Scholar
• Dong S, Wang L, Guo YB, et al. Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study. World J Surg Oncol. 2017;15(1):120. doi:10.1186/s12957-017-1175-728673297
   PubMedGoogle Scholar
• Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361–387. doi:10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-48668867
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23(13):2109–2123. doi:10.1002/sim.180215211606
   PubMed Web of Science ®Google Scholar
• Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med. 2007;35(9):2052–2056. doi:10.1097/01.CCM.0000275267.64078.B017568333
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565–574. doi:10.1177/0272989X0629536117099194
   PubMed Web of Science ®Google Scholar
• Lemke J, Scheele J, Kapapa T, Wirtz CR, Henne-Bruns D, Kornmann M. Brain metastasis in pancreatic cancer. Int J Mol Sci. 2013;14(2):4163–4173. doi:10.3390/ijms1402416323429199
   PubMed Web of Science ®Google Scholar
• Deeb A, Haque SU, Olowokure O. Pulmonary metastases in pancreatic cancer, is there a survival influence? J Gastrointest Oncol. 2015;6(3):E48–51. doi:10.3978/j.issn.2078-6891.2014.11426029466
   PubMedGoogle Scholar
• Croome KP, Jayaraman S, Schlachta CM. Preoperative staging of cancer of the pancreatic head: is there room for improvement? Can J Surg. 2010;53(3):171–174.20507789
   PubMed Web of Science ®Google Scholar
• Zamboni GA, Kruskal JB, Vollmer CM, Baptista J, Callery MP, Raptopoulos VD. Pancreatic adenocarcinoma: value of multidetector CT angiography in preoperative evaluation. Radiology. 2007;245(3):770–778. doi:10.1148/radiol.245306179517951353
   PubMed Web of Science ®Google Scholar
• Zhang L, Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zhao XM. A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma. Oncotarget. 2016;7(3):3587–3598. doi:10.18632/oncotarget.653426657296
   PubMedGoogle Scholar
• Lin Z, Yan S, Zhang J, Pan Q. A nomogram for distinction and potential prediction of liver metastasis in breast cancer patients. J Cancer. 2018;9(12):2098–2106. doi:10.7150/jca.2444529937928
   PubMed Web of Science ®Google Scholar
• Shiroyama T, Suzuki H, Tamiya M, et al. Clinical characteristics of liver metastasis in nivolumab-treated patients with non-small cell lung cancer. Anticancer Res. 2018;38(8):4723–4729. doi:10.21873/anticanres.1277930061241
   PubMed Web of Science ®Google Scholar
• Wang J, Liu J, Pan H, et al. Young age increases the risk of lymph node positivity in papillary thyroid cancer patients: a SEER data-based study. Cancer Manag Res. 2018;10:3867–3873. doi:10.2147/CMAR.S16777430288118
   PubMed Web of Science ®Google Scholar
• Mete O, Asa SL. Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol. 2011;24(12):1545–1552. doi:10.1038/modpathol.2011.11921804527
   PubMed Web of Science ®Google Scholar
• Chang DT, Pai RK, Rybicki LA, et al. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Mod Pathol. 2012;25(8):1128–1139. doi:10.1038/modpathol.2012.6122481281
   PubMed Web of Science ®Google Scholar
• Moses W, Weng J, Khanafshar E, Duh QY, Clark OH, Kebebew E. Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation. J Surg Res. 2010;160(2):179–183. doi:10.1016/j.jss.2009.05.03119765726
   PubMed Web of Science ®Google Scholar
• Romei C, Ciampi R, Elisei R. A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma. Nat Rev Endocrinol. 2016;12(4):192–202. doi:10.1038/nrendo.2016.1126868437
   PubMed Web of Science ®Google Scholar
• He C, Mao Y, Wang J, Duan F, Lin X, Li S. Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy. BMC Cancer. 2018;18(1):327. doi:10.1186/s12885-018-4242-829580215
   PubMedGoogle Scholar
• Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91(5):586–594. doi:10.1002/bjs.448415122610
   PubMed Web of Science ®Google Scholar
• Paye F, Micelli Lupinacci R, Bachellier P, Boher JM, Delpero JR. Distal pancreatectomy for pancreatic carcinoma in the era of multimodal treatment. Br J Surg. 2015;102(3):229–236. doi:10.7150/jca.2549425533421
   PubMed Web of Science ®Google Scholar
• Li HB, Zhou J, Zhao FQ. A prognostic nomogram for disease-specific survival in patients with pancreatic ductal adenocarcinoma of the head of the pancreas following pancreaticoduodenectomy. Med Sci Monitor. 2018;24:6313–6321. doi:10.12659/MSM.909649
   PubMed Web of Science ®Google Scholar
• Wu SG, Zhang WW, Sun JY, Li FY, Lin Q, He ZY. Patterns of distant metastasis between histological types in esophageal cancer. Front Oncol. 2018;8:302. doi:10.3389/fonc.2018.0030230135855
   PubMed Web of Science ®Google Scholar
• Gaitanidis A, Alevizakos M, Tsaroucha A, Tsalikidis C, Pitiakoudis M. Predictive nomograms for synchronous distant metastasis in rectal cancer. J Gastrointest Surg. 2018;22(7):1268–1276. doi:10.1007/s11605-018-3767-029663304
   PubMed Web of Science ®Google Scholar
• Hang J, Wu L, Zhu L, et al. Prediction of overall survival for metastatic pancreatic cancer: development and validation of a prognostic nomogram with data from open clinical trial and real-world study. Cancer Med. 2018;7:2974–2984. doi:10.1002/cam4.2018.7.issue-7
   PubMed Web of Science ®Google Scholar
• Liu L, Xu HX, Wang WQ, et al. Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden. Oncotarget. 2016;7(5):5943–5956. doi:10.18632/oncotarget.681926745601
   PubMedGoogle Scholar
• Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–e180. doi:10.1016/S1470-2045(14)71116-725846097
   PubMed Web of Science ®Google Scholar
• He CB, Lao XM, Lin XJ. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study. Chin J Cancer. 2017;36(1):59. doi:10.1186/s40880-017-0227-228728568
   PubMedGoogle Scholar